Prestige Brand (PBH) revenue breakdown

Healthcare · Drug Manufacturers - Specialty & Generic · Market cap $2.1B

By segment, North American OTC Healthcare is the largest at 84% of fiscal 2026 revenue; International OTC Healthcare grew fastest, 10% a year over 9 years.

By product, Gastrointestinal is the largest at 24% of fiscal 2026 revenue, growing 11% a year over 9 years.

Revenue by segment

Fiscal years, as Prestige Brand reports them in its 10-K filings; fiscal 2026 total $1.1B.

Segments2017201820192020202120222023202420252026Share
North American OTC Healthcare$721M$869M$862M$859M$849M$968M$974M$958M$960M$914M 84%
International OTC Healthcare$73M$92M$94M$104M$94M$119M$154M$167M$178M$175M 16%
Household Cleaning$88M$81M———————— —
Household Cleaning——$20M——————— —

Revenue by product

Fiscal years, as Prestige Brand reports them in its 10-K filings; fiscal 2026 total $1.1B.

Products2017201820192020202120222023202420252026Share
Gastrointestinal$101M$152M$160M$173M$161M$205M$227M$232M$256M$260M 24%
Women's Health$151M$259M$258M$252M$268M$265M$251M$240M$237M$228M 21%
Eye & Ear Care$110M$104M$113M$112M$110M$163M$171M$179M$183M$143M 13%
Dermatologicals$87M$97M$98M$103M$107M$120M$124M$129M$129M$126M 12%
Analgesics$122M$119M$114M$114M$119M$119M$119M$117M$118M$114M 10%
Cough & Cold$109M$112M$103M$111M$71M$107M$127M$119M$106M$102M 9%
Oral Care$108M$111M$103M$93M$101M$98M$98M$96M$95M$101M 9%
Other OTC$6M$6M$5M$5M$5M$10M$11M$12M$14M$15M 1%
Household Cleaning$88M$81M———————— —
Household Cleaning——$20M——————— —

Revenue by region

Fiscal years, as Prestige Brand reports them in its 10-K filings; fiscal 2026 total $1.1B.

Regions2017201820192020202120222023202420252026Share
United States$770M$904M$837M$813M$799M$910M$953M$886M$898M$850M 78%
Rest of world$112M$138M$139M$150M$144M$177M$175M$239M$240M$238M 22%
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for PBH.
Open PBH in Investingly

Questions

Where does Prestige Brand make its money?

In fiscal 2026, by segment: North American OTC Healthcare $914M, International OTC Healthcare $175M.

From Prestige Brand's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.